Literature DB >> 8205349

The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma.

G U Auer1, K M Heselmeyer, R G Steinbeck, E Munck-Wikland, A D Zetterberg.   

Abstract

This paper describes the investigation of nuclear DNA content and p53 immunoreactivity in normal mucosa (n = 25), mildly (n = 15), moderately (n = 28) and severely atypical (n = 22) colorectal adenomas and in colorectal adenocarcinomas (n = 116). Twenty-seven per cent of the mildly atypical, 43% of the moderately, 77% of the severely atypical adenomas and 91% of the colorectal carcinomas were distinctly aneuploid. In the aneuploid lesions p53 immunoreactivity was not observed in mildly atypical adenomas, whereas 17% of the moderately atypical, 24% of the severely atypical adenomas and 66% of the adenocarcinomas were p53 positive. None of the diploid lesions were p53 immunoreactive. These data are interpreted to indicate that genomic instability as reflected by crude aneuploidy occurs early during genesis of colorectal carcinoma and represents a high risk factor for p53-gene mutation.

Entities:  

Mesh:

Year:  1994        PMID: 8205349     DOI: 10.1007/bf00190554

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

Review 1.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  Nuclear DNA changes during pathogenesis of squamous carcinoma of the cervix in 3,4-benzopyrene-treated mice.

Authors:  I Näslund; C A Rubio; G U Auer
Journal:  Anal Quant Cytol Histol       Date:  1987-10       Impact factor: 0.302

3.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.

Authors:  W Maltzman; L Czyzyk
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

4.  DNA content and survival in mammary carcinoma.

Authors:  G U Auer; T O Caspersson; A S Wallgren
Journal:  Anal Quant Cytol       Date:  1980-09

5.  Prognostic value of nuclear DNA content in papillary thyroid carcinoma.

Authors:  K Cohn; M Bäckdahl; G Forsslund; G Auer; G Lundell; T Löwhagen; E Tallroth; J S Willems; A Zetterberg; P O Granberg
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

Review 6.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

7.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

8.  Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

Authors:  J Bártek; J Bártková; B Vojtĕsek; Z Stasková; J Lukás; A Rejthar; J Kovarík; C A Midgley; J V Gannon; D P Lane
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

9.  Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.

Authors:  P Carder; A H Wyllie; C A Purdie; R G Morris; S White; J Piris; C C Bird
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

10.  Over-expression of p53 nuclear oncoprotein in colorectal adenomas.

Authors:  M Pignatelli; G W Stamp; G Kafiri; D Lane; W F Bodmer
Journal:  Int J Cancer       Date:  1992-03-12       Impact factor: 7.396

View more
  6 in total

Review 1.  pRB, a tumor suppressor with a stabilizing presence.

Authors:  Amity L Manning; Nicholas J Dyson
Journal:  Trends Cell Biol       Date:  2011-06-12       Impact factor: 20.808

2.  The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma.

Authors:  S Biesterfeld; H Schreiber
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53.

Authors:  J E Hundley; S K Koester; D A Troyer; S G Hilsenbeck; M A Subler; J J Windle
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

4.  Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.

Authors:  M Salih Deveci; Güzin Deveci
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

5.  Nuclear image analysis of immunohistochemically stained cells in breast carcinomas.

Authors:  G Haroske; V Dimmer; K Friedrich; W Meyer; B Thieme; F Theissig; K D Kunze
Journal:  Histochem Cell Biol       Date:  1996-06       Impact factor: 4.304

6.  The Correlation between EGFR Mutation Status and DNA Content of Lung Adenocarcinoma Cells in Pleural Effusion.

Authors:  Yun Du; Xiao Guo; Rui Wang; Yang Ma; Yan Zhang; Ying Liu; Lvli Dong; Juan Wu; Xiaokun Ji; Heng Wang
Journal:  J Cancer       Date:  2020-02-06       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.